Cart
sales@molnova.com
NVP-BEP800
CAS No. 847559-80-2
NVP-BEP800( VER-82576 | VER82576 )
Catalog No. M16151 CAS No. 847559-80-2
A potent and selective Hsp90β inhibitor with IC50 of 58 nM; shows >70-fold selective against Grp94 and Trap-1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | In Stock |
|
| 5MG | 77 | In Stock |
|
| 10MG | 135 | In Stock |
|
| 25MG | 228 | In Stock |
|
| 50MG | 412 | In Stock |
|
| 100MG | 606 | In Stock |
|
| 500MG | 1287 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNVP-BEP800
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective Hsp90β inhibitor with IC50 of 58 nM; shows >70-fold selective against Grp94 and Trap-1.
-
DescriptionA potent and selective Hsp90β inhibitor with IC50 of 58 nM; shows >70-fold selective against Grp94 and Trap-1; induces ErbB2, B-Raf(V600E), Raf-1, Akt and Hsp70 induction in A375 melanoma and BT-474 breast cancer cell lines; orally bioactive.Breast Cancer Preclinical.
-
In VitroVER-82576 (NVP-BEP800) is a potent and selective Hsp90 inhibitor, with an IC50 of 58 nM for Hsp90β and is >70-fold selective against Grp94 and Trap-1, with IC50s of 4.1 ± 1.1 and 5.5 ± 0.48 μM. VER-82576 potently inhibits the proliferation of tumor cells, with GI50s ranging from 38 nM in A375 cells to 1050 nM in PC3 cells, with an average GI50 of 245 nM. VER-82576 (250-1250 nM) depletes client proteins in human cancer cell lines in vitro. VER-82576 (NVP-BEP800; 200 nM) shows no significant effect on the ionizing radiation (IR) dose-response curves of A549 cells, and is less toxic to SNB19 cells. VER-82576 in combination with IR results in more severe DNA damage in both A549 and SNB19 cell lines than each treatment alone and also protracts the kinetics of DNA damage repair in SNB19 cells. VER-82576 (NVP-BEP800; 0.05, 0.1 or 0.2 μM) dose-dependently decreases the viability and induces apoptosis of glioblastoma cells. VER-82576 (0.2 μM) suppresses the expression of IKKβ protein but does not alter the levels of IKKβ mRNA in T98G cells. VER-82576 (0.2 μM) suppresses the expression of heat shock protein 70.
-
In VivoVER-82576 (NVP-BEP800; 15 or 30 mg/kg, p.o.) shows antitumor activities in A375 cancer xenografts and BT-474 xenograft-bearing mice.
-
SynonymsVER-82576 | VER82576
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetHSP
-
RecptorHSP90β
-
Research AreaCancer
-
IndicationBreast Cancer
Chemical Information
-
CAS Number847559-80-2
-
Formula Weight480.4106
-
Molecular FormulaC21H23Cl2N5O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 6.2 mg/mL (Need ultrasonic)
-
SMILESO=C(C1=CC2=C(C3=CC(OCCN4CCCC4)=C(Cl)C=C3Cl)N=C(N)N=C2S1)NCC
-
Chemical NameThieno[2,3-d]pyrimidine-6-carboxamide, 2-amino-4-[2,4-dichloro-5-[2-(1-pyrrolidinyl)ethoxy]phenyl]-N-ethyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Massey AJ, et al. Mol Cancer Ther. 2010 Apr;9(4):906-19.
2. Brough PA, et al. J Med Chem. 2009 Aug 13;52(15):4794-809.
3. Stingl L, et al. Br J Cancer. 2010 May 25;102(11):1578-91.
molnova catalog
related products
-
JG-231
JG-231 is an allosteric inhibitor that disrupts the Hsp70-BAG3 interaction (Ki=0.11 uM).
-
A-674563 HCl
A-674563 is an orally available, ATP-competitive, and reversible inhibitor of Akt (Ki: 11 nM for Akt1) .
-
AMP-PCP disodium
AMP-PCP disodium, an ATP analogue, binds to the N-terminal domain of Hsp90 with a Kd value of 3.8 μM, facilitating the formation of an active Hsp90 homodimer.
